Company intelligence / Profile preview

Hebei Veyong Pharmaceutical

Shijiazhuang, Hebei, China

Ownership: Private
Development stage: Other

Overview

Hebei Veyong Pharmaceutical is a leading Chinese veterinary pharma company with commercial products including APIs and finished dosage veterinary drugs such as Ivermectin, Tiamulin Fumarate, and Oxytetracycline; several products have passed EU COS, US FDA, and other global certifications, and products are exported to over 70 countries.

Therapeutic areas: Infectious DiseasesPulmonologyGastroenterology
Modalities: Small moleculeBiologic
Industry: Veterinary

Partnerships

Cooperation with many internationally known animal pharmaceutical enterprises (unnamed)

Beyond the preview

Go deeper on Hebei Veyong Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hebei Veyong Pharmaceutical.

Explore the full profile